SCHEMBL4841208

SCHEMBL4841208

COc1ccc2c(c1)C(=CC(=O)c1cccc(NS(=O)(=O)c3ccc(S(=O)(=O)c4ccccc4)s3)c1)NC(C)(C)C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.39
ALDH1A1 P00352 4/20 0.39
KMT2A Q03164 5/20 0.38
MEN1 O00255 4/20 0.38
PKM P14618 2/20 0.38
TCF4 P15884 1/20 0.38
CTNNB1 P35222 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
MAPT P10636 3/20 0.38
HTT P42858 3/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 2/20 0.38
ALOX12 P18054 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TYMS P04818 1/20 0.36
EGFR P00533 2/20 0.36
FGFR1 P11362 2/20 0.36
KDR P35968 2/20 0.36
GAA P10253 1/20 0.36
PFKFB3 Q16875 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841194 1.00 LMNA (0.39) LMNAALDH1A1KMT2AMEN1PKM
SCHEMBL4844453 0.93 ALDH1A1 (0.37) LMNAALDH1A1KMT2AMEN1PKM
SCHEMBL4844469 0.93 ALDH1A1 (0.37) LMNAALDH1A1KMT2AMEN1PKM
SCHEMBL4843113 0.86 TP53 (0.44) LMNAALDH1A1KMT2AMEN1TCF4
SCHEMBL4843108 0.86 TP53 (0.44) LMNAALDH1A1KMT2AMEN1TCF4
SCHEMBL4844620 0.86 TCF4 (0.47) LMNAALDH1A1KMT2AMEN1PKM
SCHEMBL4844632 0.86 TCF4 (0.47) LMNAALDH1A1KMT2AMEN1PKM
SCHEMBL4838075 0.85 MAPT (0.39) LMNAALDH1A1KMT2AMEN1TCF4
SCHEMBL4838064 0.85 MAPT (0.39) LMNAALDH1A1KMT2AMEN1TCF4
SCHEMBL4835345 0.84 TCF4 (0.49) LMNAALDH1A1KMT2AMEN1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 LMNA 3014/4885ALDH1A1 2636/4885KMT2A 4642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.